ATRICURE SYNERGY ABLATION SYSTEMS
Device
AtriCure, Inc.
Total Payments
$743,855
Transactions
452
Doctors
11
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $743,855 | 452 | 11 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $672,042 | 379 | 90.3% |
| Consulting Fee | $64,675 | 33 | 8.7% |
| Travel and Lodging | $6,979 | 31 | 0.9% |
| Food and Beverage | $159.09 | 9 | 0.0% |
Payments by Type
Research
$672,042
379 transactions
General
$71,813
73 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CONVERGENCE OF EPICARDIAL AND ENDOCARDIAL RF ABLATION FOR THE TREATMENT OF SYMPTOMATIC PERSISTENT AF | ATRICURE, INC. | $258,341 | 0 |
| PIVOTAL STUDY OF A DUAL EPICARDIAL AND ENDOCARDIAL PROCEDURE (DEEP) APPROACH FOR TREATMENT OF SUBJECTS WITH PERSISTENT OR LONG STANDING PERSISTENT ATRIAL FIBRILLATION WITH RADIOFREQUENCY ABLATION | ATRICURE, INC. | $211,492 | 0 |
| ATRICURE CRYOICE LESIONS FOR PERSISTENT AND LONGSTANDING PERSISTENT ATRIAL FIBRILLATION TREATMENT DURING CONCOMITANT ON-PUM ENDO/EPICARDIAL CARDIAC SURGERY | ATRICURE, INC. | $132,009 | 0 |
| ATRICURE CRYOICE LESIONS FOR PERSISTENT AND LONGSTANDING PERSISTENT ATRIAL FIBRILLATION TREATMENT DURING CONCOMITANT ON-PUM ENDO/EPICARDIAL CARDIAC SURGERY | AtriCure, Inc. | $50,536 | 1 |
| CONVERGENCE OF EPICARDIAL AND ENDOCARDIAL RF ABLATION FOR THE TREATMENT OF SYMPTOMATIC PERSISTENT AF | AtriCure, Inc. | $19,663 | 2 |
Top Doctors Receiving Payments for ATRICURE SYNERGY ABLATION SYSTEMS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Tupelo, MS | $610,843 | 374 |
| , M.D | Surgery | Takoma Park, MD | $41,536 | 2 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Oakland, CA | $22,516 | 35 |
| , MD | Surgery | Dublin, OH | $21,328 | 14 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Meridian, ID | $20,212 | 13 |
| , M.D | Cardiovascular Disease | Baltimore, MD | $13,813 | 2 |
| , M.D | Clinical Cardiac Electrophysiology | Atlanta, GA | $5,850 | 1 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Downers Grove, IL | $3,500 | 4 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Saint Louis, MO | $2,475 | 1 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | New York, NY | $900.00 | 1 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Stockton, CA | $712.94 | 4 |
| , M.D | Internal Medicine | Webster, TX | $169.00 | 1 |
Ad
Manufacturing Companies
- ATRICURE, INC. $601,843
- AtriCure, Inc. $142,012
Product Information
- Type Device
- Total Payments $743,855
- Total Doctors 11
- Transactions 452
About ATRICURE SYNERGY ABLATION SYSTEMS
ATRICURE SYNERGY ABLATION SYSTEMS is a device associated with $743,855 in payments to 11 healthcare providers, recorded across 452 transactions in the CMS Open Payments database. The primary manufacturer is AtriCure, Inc..
Payment data is available from 2019 to 2019. In 2019, $743,855 was paid across 452 transactions to 11 doctors.
The most common payment nature for ATRICURE SYNERGY ABLATION SYSTEMS is "Unspecified" ($672,042, 90.3% of total).
ATRICURE SYNERGY ABLATION SYSTEMS is associated with 5 research studies, including "CONVERGENCE OF EPICARDIAL AND ENDOCARDIAL RF ABLATION FOR THE TREATMENT OF SYMPTOMATIC PERSISTENT AF" ($258,341).